# Trajectories of Treatment Response as Window Into the Heterogeneity of Psychosis: a Longitudinal Multimodal Imaging Study

> **NCT03442101** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of Alabama at Birmingham** · enrollment: 156 (actual)

## Conditions studied

- Psychosis

## Interventions

- **DRUG:** Patients with psychosis will be treated with known antipsychotic medication

## Key facts

- **NCT ID:** NCT03442101
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-04-01
- **Primary completion:** 2026-12-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 156 (ACTUAL)
- **Last updated:** 2026-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03442101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03442101, "Trajectories of Treatment Response as Window Into the Heterogeneity of Psychosis: a Longitudinal Multimodal Imaging Study". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03442101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*